Duke University s Brain Cancer Genomics Lab Taps Agencourt to Help Research | GenomeWeb

NEW YORK, March 25 - Agencourt Bioscience on Monday said that the Duke University Medical Center has picked its Solid Phase Reversible Immobilization technology to help its cancer research.

The deal, funded by the National Cancer Institute's Cancer Genome Anatomy Project, will give researchers at Duke's Brain Cancer Genomics Laboratory access to Agencourt's SPRI technology to help them determine the molecular anatomy of normal, pre-cancer, and cancer cells. Terms also call for Agencourt to sequence Duke's SAGE libraries.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: genetic target for urothelial bladder cancer treatment, and more.

At the Conversation, the University of Oxford's Michael Macklay writes that learning genetic risk of disease is a personal decision.

Two dozen scientific organizations have endorsed the March for Science, according to ScienceInsider.

Researchers in Japan describe a chimpanzee with a chromosomal abnormality similar to human Down syndrome, Mashable reports.